STACEY KANE — Lobbyist Profile | Poliscope

STACEY KANE

Reported covered position: N/A

Filings

Clients

Firms

Years active

1999–2003

Associated filing income

$280,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
ACCENTURE	2	1999
UNITED NETWORK FOR ORGAN SHARING	2	1999
AMERICAN MEDICAL RESPONSE	1	1999
BRISTOL MYERS SQUIBB	1	2003
GLAXOSMITHKLINE	1	2003
JOHNSON & JOHNSON	1	1999

Firm	Filings	Years
BKSH & ASSOCIATES	8	1999–2003

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

Pharmaceutical Market Access Act of 2003

Cited source text

H.R. 2427, Reimportation of prescription drugs legislation.

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

2003 · year_end · YA

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MMM

Medicare/Medicaid

H.R. 1, Medicare Prescription Drug and Modernization Act of 2003; S. 1, Prescription Drug and Medicare Improvement Act of 2003.

BUD

Budget/Appropriations

FY '04 Labor, HHS and Education and Related Agencies Appropriations Bill.

Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE